2024-08-31 2025-08-30 2025-08-30 false 09195592 RISEUP HEALTHCARE LTD 2026-04-02 false iso4217:GBP xbrli:pure 09195592 2024-08-30 09195592 2025-08-30 09195592 2024-08-31 2025-08-30 09195592 2023-08-31 09195592 2024-08-30 09195592 2023-09-01 2024-08-30 09195592 bus:SmallEntities 2024-08-31 2025-08-30 09195592 bus:AuditExempt-NoAccountantsReport 2024-08-31 2025-08-30 09195592 bus:FullAccounts 2024-08-31 2025-08-30 09195592 bus:PrivateLimitedCompanyLtd 2024-08-31 2025-08-30 09195592 core:WithinOneYear 2025-08-30 09195592 core:AfterOneYear 2025-08-30 09195592 core:WithinOneYear 2024-08-30 09195592 core:AfterOneYear 2024-08-30 09195592 core:ShareCapital 2025-08-30 09195592 core:SharePremium 2025-08-30 09195592 core:RevaluationReserve 2025-08-30 09195592 core:OtherReservesSubtotal 2025-08-30 09195592 core:RetainedEarningsAccumulatedLosses 2025-08-30 09195592 core:ShareCapital 2024-08-30 09195592 core:SharePremium 2024-08-30 09195592 core:RevaluationReserve 2024-08-30 09195592 core:OtherReservesSubtotal 2024-08-30 09195592 core:RetainedEarningsAccumulatedLosses 2024-08-30 09195592 core:LandBuildings 2025-08-30 09195592 core:PlantMachinery 2025-08-30 09195592 core:Vehicles 2025-08-30 09195592 core:FurnitureFittings 2025-08-30 09195592 core:OfficeEquipment 2025-08-30 09195592 core:NetGoodwill 2025-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2025-08-30 09195592 core:ListedExchangeTraded 2025-08-30 09195592 core:UnlistedNon-exchangeTraded 2025-08-30 09195592 core:LandBuildings 2024-08-30 09195592 core:PlantMachinery 2024-08-30 09195592 core:Vehicles 2024-08-30 09195592 core:FurnitureFittings 2024-08-30 09195592 core:OfficeEquipment 2024-08-30 09195592 core:NetGoodwill 2024-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2024-08-30 09195592 core:ListedExchangeTraded 2024-08-30 09195592 core:UnlistedNon-exchangeTraded 2024-08-30 09195592 core:LandBuildings 2024-08-31 2025-08-30 09195592 core:PlantMachinery 2024-08-31 2025-08-30 09195592 core:Vehicles 2024-08-31 2025-08-30 09195592 core:FurnitureFittings 2024-08-31 2025-08-30 09195592 core:OfficeEquipment 2024-08-31 2025-08-30 09195592 core:NetGoodwill 2024-08-31 2025-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 2025-08-30 09195592 core:ListedExchangeTraded 2024-08-31 2025-08-30 09195592 core:UnlistedNon-exchangeTraded 2024-08-31 2025-08-30 09195592 core:MoreThanFiveYears 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments 2025-08-30 09195592 core:Non-currentFinancialInstruments 2024-08-30 09195592 dpl:CostSales 2024-08-31 2025-08-30 09195592 dpl:DistributionCosts 2024-08-31 2025-08-30 09195592 core:LandBuildings 2024-08-31 2025-08-30 09195592 core:PlantMachinery 2024-08-31 2025-08-30 09195592 core:Vehicles 2024-08-31 2025-08-30 09195592 core:FurnitureFittings 2024-08-31 2025-08-30 09195592 core:OfficeEquipment 2024-08-31 2025-08-30 09195592 dpl:AdministrativeExpenses 2024-08-31 2025-08-30 09195592 core:NetGoodwill 2024-08-31 2025-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 2025-08-30 09195592 dpl:GroupUndertakings 2024-08-31 2025-08-30 09195592 dpl:ParticipatingInterests 2024-08-31 2025-08-30 09195592 dpl:GroupUndertakings core:ListedExchangeTraded 2024-08-31 2025-08-30 09195592 core:ListedExchangeTraded 2024-08-31 2025-08-30 09195592 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-08-31 2025-08-30 09195592 core:UnlistedNon-exchangeTraded 2024-08-31 2025-08-30 09195592 dpl:CostSales 2023-09-01 2024-08-30 09195592 dpl:DistributionCosts 2023-09-01 2024-08-30 09195592 core:LandBuildings 2023-09-01 2024-08-30 09195592 core:PlantMachinery 2023-09-01 2024-08-30 09195592 core:Vehicles 2023-09-01 2024-08-30 09195592 core:FurnitureFittings 2023-09-01 2024-08-30 09195592 core:OfficeEquipment 2023-09-01 2024-08-30 09195592 dpl:AdministrativeExpenses 2023-09-01 2024-08-30 09195592 core:NetGoodwill 2023-09-01 2024-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-30 09195592 dpl:GroupUndertakings 2023-09-01 2024-08-30 09195592 dpl:ParticipatingInterests 2023-09-01 2024-08-30 09195592 dpl:GroupUndertakings core:ListedExchangeTraded 2023-09-01 2024-08-30 09195592 core:ListedExchangeTraded 2023-09-01 2024-08-30 09195592 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-30 09195592 core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-30 09195592 core:NetGoodwill 2025-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2025-08-30 09195592 core:LandBuildings 2025-08-30 09195592 core:PlantMachinery 2025-08-30 09195592 core:Vehicles 2025-08-30 09195592 core:FurnitureFittings 2025-08-30 09195592 core:OfficeEquipment 2025-08-30 09195592 core:AfterOneYear 2025-08-30 09195592 core:WithinOneYear 2025-08-30 09195592 core:ListedExchangeTraded 2025-08-30 09195592 core:UnlistedNon-exchangeTraded 2025-08-30 09195592 core:ShareCapital 2025-08-30 09195592 core:SharePremium 2025-08-30 09195592 core:RevaluationReserve 2025-08-30 09195592 core:OtherReservesSubtotal 2025-08-30 09195592 core:RetainedEarningsAccumulatedLosses 2025-08-30 09195592 core:NetGoodwill 2024-08-30 09195592 core:IntangibleAssetsOtherThanGoodwill 2024-08-30 09195592 core:LandBuildings 2024-08-30 09195592 core:PlantMachinery 2024-08-30 09195592 core:Vehicles 2024-08-30 09195592 core:FurnitureFittings 2024-08-30 09195592 core:OfficeEquipment 2024-08-30 09195592 core:AfterOneYear 2024-08-30 09195592 core:WithinOneYear 2024-08-30 09195592 core:ListedExchangeTraded 2024-08-30 09195592 core:UnlistedNon-exchangeTraded 2024-08-30 09195592 core:ShareCapital 2024-08-30 09195592 core:SharePremium 2024-08-30 09195592 core:RevaluationReserve 2024-08-30 09195592 core:OtherReservesSubtotal 2024-08-30 09195592 core:RetainedEarningsAccumulatedLosses 2024-08-30 09195592 core:NetGoodwill 2023-08-31 09195592 core:IntangibleAssetsOtherThanGoodwill 2023-08-31 09195592 core:LandBuildings 2023-08-31 09195592 core:PlantMachinery 2023-08-31 09195592 core:Vehicles 2023-08-31 09195592 core:FurnitureFittings 2023-08-31 09195592 core:OfficeEquipment 2023-08-31 09195592 core:AfterOneYear 2023-08-31 09195592 core:WithinOneYear 2023-08-31 09195592 core:ListedExchangeTraded 2023-08-31 09195592 core:UnlistedNon-exchangeTraded 2023-08-31 09195592 core:ShareCapital 2023-08-31 09195592 core:SharePremium 2023-08-31 09195592 core:RevaluationReserve 2023-08-31 09195592 core:OtherReservesSubtotal 2023-08-31 09195592 core:RetainedEarningsAccumulatedLosses 2023-08-31 09195592 core:AfterOneYear 2024-08-31 2025-08-30 09195592 core:WithinOneYear 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:CostValuation 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-31 2025-08-30 09195592 core:Non-currentFinancialInstruments core:CostValuation 2025-08-30 09195592 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-08-30 09195592 core:Non-currentFinancialInstruments core:CostValuation 2024-08-30 09195592 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-30 09195592 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-30 09195592 bus:Director1 2024-08-31 2025-08-30 09195592 core:FurnitureFittingsToolsEquipment 2024-08-30 09195592 core:FurnitureFittingsToolsEquipment 2025-08-30 09195592 core:FurnitureFittingsToolsEquipment 2024-08-31 2025-08-30

RISEUP HEALTHCARE LTD

Registered Number
09195592
(England and Wales)

Unaudited Financial Statements for the Year ended
30 August 2025

RISEUP HEALTHCARE LTD
Company Information
for the year from 31 August 2024 to 30 August 2025

Director | BHANDARI, Poonam

Registered Address | Dorley House
| Norwich Road
| Besthorpe
| NR17 2LB

Registered Number | 09195592 (England and Wales)

RISEUP HEALTHCARE LTD
Statement of Financial Position
30 August 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 1,625 |  |  |  | 6,352
|  |  |  | 1,625 |  |  |  | 6,352
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 1,296,064 |  |  |  | 909,210 |  |
Cash at bank and on hand |  | 436,665 |  |  |  | 499,404 |  |
|  | 1,732,729 |  |  |  | 1,408,614 |  |
Creditors amounts falling due within one year | 5 | (180,422) |  |  |  | (167,309) |  |
Net current assets (liabilities) |  |  |  | 1,552,307 |  |  |  | 1,241,305
Total assets less current liabilities |  |  |  | 1,553,932 |  |  |  | 1,247,657
Net assets |  |  |  | 1,553,932 |  |  |  | 1,247,657
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Other reserves |  |  |  | 5,000 |  |  |  | 5,000
Profit and loss account |  |  |  | 1,548,832 |  |  |  | 1,242,557
Shareholders' funds |  |  |  | 1,553,932 |  |  |  | 1,247,657

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 2 April 2026, and are signed on its behalf by:
BHANDARI, Poonam Director Registered Company No. 09195592

RISEUP HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 30 August 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

| Employee benefits
--- | ---
| Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

| Investments
--- | ---
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

| Related parties
--- | ---
| For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.

| Government grants or assistance
--- | ---
| Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 45 |  | 40

3. | Tangible fixed assets
--- | ---

|  | Vehicles |  | Fixtures & fittings |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
| Cost or valuation
| At 31 August 24 | 22,789 |  | 247 |  | 2,993 |  | 26,029
| At 30 August 25 | 22,789 |  | 247 |  | 2,993 |  | 26,029
| Depreciation and impairment
| At 31 August 24 | 19,142 |  | 48 |  | 487 |  | 19,677
| Charge for year | 3,647 |  | 82 |  | 998 |  | 4,727
| At 30 August 25 | 22,789 |  | 130 |  | 1,485 |  | 24,404
| Net book value
| At 30 August 25 | - |  | 117 |  | 1,508 |  | 1,625
| At 30 August 24 | 3,647 |  | 199 |  | 2,506 |  | 6,352

4. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 656,890 |  | 404,390
| Other debtors | 639,174 |  | 504,820
| Total | 1,296,064 |  | 909,210

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 134,617 |  | 129,958
| Other creditors | 44,921 |  | 37,243
| Accrued liabilities and deferred income | 884 |  | 108
| Total | 180,422 |  | 167,309

6. | Related party transactions
--- | ---
| At the period end, included in other debtors, is a balance of £635,000 (2023: £480,000) due from Riseup Properties Limited, a company in which Poonam Bhandari is a director. During the period, interest of £Nil was received on this balance. At the period end, included in other creditors, is a balance of £3,199 (2023: £3,199) due to Poonam Bhandari who is a director of Riseup Properties Limited.